調査レポートカテゴリー： MarketsandMarkets, 世界, 部品/材料

Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer, Infectious), Research, Forensic), End User (Hospitals, Diagnostic Laboratories, Academic) - Global Forecast to 2025

免疫組織化学（IHC）の世界市場予測：製品別（抗体、試薬（発色性基質）、キット）、用途別（診断（癌、感染症）、研究、法医学）、エンドユーザー別（病院、診断研究所、学術）

◆タイトル：Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer, Infectious), Research, Forensic), End User (Hospitals, Diagnostic Laboratories, Academic) - Global Forecast to 2025
◆商品コード：BT 4780
◆調査・発行会社：MarketsandMarkets
◆発行日：2020年8月28日
◆ページ数：226
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：化学
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥847,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

MarketsandMarkets社は免疫組織化学（IHC）の世界市場が2020年19億から2025年27億ドルまで、年平均6.6％成長すると予測しております。本調査レポートでは、免疫組織化学（IHC）の世界市場について詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（抗体、試薬、機器、キット）分析、用途別（癌、研究、法医学）分析、エンドユーザー別（病院・診断研究所、学術・研究機関、その他）分析、地域別分析、競争状況、企業評価・情報などを含めております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・免疫組織化学（IHC）の世界市場規模：製品別（抗体、試薬、機器、キット）
・免疫組織化学（IHC）の世界市場規模：用途別（癌、研究、法医学）
・免疫組織化学（IHC）の世界市場規模：エンドユーザー別（病院・診断研究所、学術・研究機関、その他）
・免疫組織化学（IHC）の世界市場規模：地域別
・競争状況
・企業評価・情報

“Increasing incidence of chronic diseases, and technological advancements in IHC are set to drive the IHC market.’’
The global immunohistochemistry market is projected to reach USD 2.7 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 6.6% during the forecast period. The increasing incidence and prevalence of cancer, technological advancements in IHC, and the availability of reimbursement for IHC tests are the major factors driving the growth of this market. However, the high degree of consolidation is expected to restrain the growth of this market during the forecast period

“By antibodies type, the primary antibodies accounted for the fasted growing antibody segment of the IHC market”
The antibodies segment includes primary antibodies and secondary antibodies. The primary antibodies segment accounted for the fastest growing IHC antibodymarket. Factors such as improved approval rate for therapeutic antibodies by regulatory authorities, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies. Also, the mandatory use of primary antibodies in IHC protocols and their extensive application in diverse diagnostic and research areas have resulted in continuous demand for these antibodies.
“By equipment type, the slide-staining systems segment accounted for the largest share of the IHC equipement market”
Based on equipment type, the IHC equipment segment is further divided into slide-staining systems, tissue processing systems, slide scanners, and other equipment (automated cover slippers, microtomes, paraffin dispensers, tissue microarrays, and slide labelers). The slide-staining systems accounted for the largest share of IHC market, by equipment. Development of high-throughput staining systems is one of the major factor driving market growth.

“Asia Pacific: The fastest-growing region in the IHC market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the large population in emerging economies such as China, India, and Japan; rising prevalence of chronic diseases; rising demand for quality medical care; and the increasing healthcare spending are expected to boost the IHC market in the Asia Pacific.
“North America: the largest share of the IHC market”
North America accounted for the largest share of the IHC market. The large share of this segment can primarily be attributed to the to the presence of major players operating in the IHC market in the US, rising incidence of cancer and infectious diseases, and the increasing adoption of companion diagnostic assay kits.

Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
• By Respondent– Supply Side- 80%, Demand Side-20%
• By Designation— Executives- 25%, CXOs- 20%, Managers – 55%
• By Region— North America – 50%, Europe – 20%, APAC – 20%, RoW- 10%

The IHC market is dominated by a few globally established players such as F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Sakura Finetek Japan Co., Ltd. (Japan), Abcam plc (UK), Becton, Dickinson and Company (US), Histo-Line Laboratories (Italy), Bio SB, Inc. (US), Diagnostic BioSystems (US), BioGenex (US), Bio-Rad Laboratories, Inc. (US), Biocare Medical, LLC. (US), Miltenyi Biotec (US), CANDOR Bioscience GmbH (Germany), EagleBio (US), Cell Signaling Technology, Inc. (US), Enzo Biochem Inc. (US), BioVision, Inc. (US), Elabscience, Inc. (China), Amos Scientific Pty Ltd. (Australia), Bio-Techne (US), and Jinhua YIDI Medical Appliance CO., LTD. (China)

Research Coverage:
The report segments the IHC market based on region (Asia Pacific, Europe, North America, and RoW), product (antibodies, equipment, kits, and reagents), application (diagnostics, research, and forensic), and end user (hospitals & diagnostic laboratories, academic & research institutes, and other end users).
The report also provides a comprehensive review of market drivers, restraints, challenges, and opportunities in the IHC market

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the IHC market and provides them information on key market drivers, restraints, challenges, and opportunities.

【レポートの目次】

1 INTRODUCTION 35
1.1 OBJECTIVES OF THE STUDY 35
1.2 MARKET DEFINITION 36
1.2.1 INCLUSIONS & EXCLUSIONS 36
1.3 MARKET SCOPE 37
1.3.1 MARKETS COVERED 37
1.3.2 YEARS CONSIDERED FOR THE STUDY 37
1.4 CURRENCY 38
1.5 LIMITATIONS 38
1.6 STAKEHOLDERS 38
1.7 SUMMARY OF CHANGES 39

2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
2.1.1 SECONDARY DATA 40
2.1.2 PRIMARY DATA 41
FIGURE 1 BREAKDOWN OF PRIMARIES: IMMUNOHISTOCHEMISTRY MARKET 41
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION 42
2.1.4 DATA TRIANGULATION 42
FIGURE 2 DATA TRIANGULATION METHODOLOGY 42
2.2 MARKET ESTIMATION METHODOLOGY 43
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE
ANALYSIS-BASED ESTIMATION) 43
FIGURE 4 IMMUNOHISTOCHEMISTRY MARKET SIZE (USD BILLION) 43
FIGURE 5 IMMUNOHISTOCHEMISTRY MARKET: FINAL CAGR
PROJECTIONS (2020−2025) 44
FIGURE 6 IMMUNOHISTOCHEMISTRY MARKET: CAGR PROJECTIONS FROM
THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES 44
2.3 INDUSTRY INSIGHTS 45
2.4 RESEARCH ASSUMPTIONS 45

3 EXECUTIVE SUMMARY 46
FIGURE 7 IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION) 46
FIGURE 8 IMMUNOHISTOCHEMISTRY MARKET SHARE, BY APPLICATION, 2019 46
FIGURE 9 IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2020−2025 47
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE IMMUNOHISTOCHEMISTRY MARKET 48
 
4 PREMIUM INSIGHTS 49
4.1 IMMUNOHISTOCHEMISTRY MARKET OVERVIEW 49
FIGURE 11 TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET GROWTH 49
4.2 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET SHARE,
BY END USER AND COUNTRY (2019) 50
FIGURE 12 HOSPITALS & DIAGNOSTIC LABORATORIES SEGMENT ACCOUNTED FOR
THE LARGEST SHARE OF THE ASIA PACIFIC IHC MARKET IN 2019 50
4.3 IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE 50
FIGURE 13 PRIMARY ANTIBODIES SEGMENT WILL CONTINUE TO DOMINATE
THE IHC ANTIBODIES MARKET IN THE FORECAST PERIOD 50

5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
FIGURE 14 IMMUNOHISTOCHEMISTRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
5.2.1 DRIVERS 52
5.2.1.1 Growing incidence and prevalence of cancer 52
FIGURE 15 CANCER INCIDENCE, BY REGION AND TYPE OF CANCER, 2018 52
5.2.1.2 Technological advancements in IHC 52
5.2.1.3 Availability of reimbursements for IHC tests 53
TABLE 1 CPT CODES FOR IHC PROCEDURES 53
5.2.2 RESTRAINTS 53
5.2.2.1 High degree of consolidation 53
TABLE 2 MAJOR ACQUISITIONS IN THE MARKET, 2015–2020 54
5.2.3 OPPORTUNITIES 54
5.2.3.1 Increasing demand for personalized medicine 54
5.2.4 CHALLENGES 55
5.2.4.1 Dearth of skilled professionals 55
TABLE 3 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018 55
5.2.4.2 Product failures and recalls 55
5.3 IMPACT OF COVID-19 ON THE IMMUNOHISTOCHEMISTRY MARKET 56

6 IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT 58
6.1 INTRODUCTION 59
TABLE 4 IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 59
6.2 ANTIBODIES 59
TABLE 5 IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY REGION,
2018–2025 (USD MILLION) 60
TABLE 6 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES,
BY COUNTRY, 2018–2025 (USD MILLION) 60
TABLE 7 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES,
BY COUNTRY, 2018–2025 (USD MILLION) 60
TABLE 8 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY COUNTRY, 2018–2025 (USD MILLION) 61
TABLE 9 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY REGION, 2018–2025 (USD MILLION) 61
TABLE 10 IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE,
2018–2025 (USD MILLION) 61
6.2.1 PRIMARY ANTIBODIES 62
6.2.1.1 Wide applications in diagnostics and research to support the demand for primary antibodies 62
TABLE 11 IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY REGION, 2018–2025 (USD MILLION) 62
TABLE 12 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2018–2025 (USD MILLION) 62
TABLE 13 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES,
BY COUNTRY, 2018–2025 (USD MILLION) 63
TABLE 14 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES,
BY COUNTRY, 2018–2025 (USD MILLION) 63
TABLE 15 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES,
BY REGION, 2018–2025 (USD MILLION) 63
6.2.2 SECONDARY ANTIBODIES 64
6.2.2.1 Signal amplification through conjugation and comparatively easy manufacturing to drive the market for secondary antibodies 64
TABLE 16 IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES,
BY REGION, 2018–2025 (USD MILLION) 64
TABLE 17 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2018–2025 (USD MILLION) 64
TABLE 18 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2018–2025 (USD MILLION) 65
TABLE 19 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES,
BY COUNTRY, 2018–2025 (USD MILLION) 65
TABLE 20 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES,
BY REGION, 2018–2025 (USD MILLION) 65
6.3 REAGENTS 66
TABLE 21 IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY REGION,
2018–2025 (USD MILLION) 66
TABLE 22 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS,
BY COUNTRY, 2018–2025 (USD MILLION) 66
TABLE 23 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2018–2025 (USD MILLION) 67
TABLE 24 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2018–2025 (USD MILLION) 67
TABLE 25 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY REGION, 2018–2025 (USD MILLION) 67
TABLE 26 IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE,
2018–2025 (USD MILLION) 68
6.3.1 HISTOLOGICAL STAINS 68
6.3.1.1 Developments in tumor detection and cancer disease progression studies to propel market growth 68
TABLE 27 IMMUNOHISTOCHEMISTRY MARKET FOR HISTOLOGICAL STAINS, BY REGION, 2018–2025 (USD MILLION) 68
6.3.2 BLOCKING SERA AND REAGENTS 69
6.3.2.1 Blocking sera and reagents prevent the nonspecific binding
activity of antibodies 69
TABLE 28 IMMUNOHISTOCHEMISTRY MARKET FOR BLOCKING SERA AND REAGENTS, BY REGION, 2018–2025 (USD MILLION) 69
6.3.3 CHROMOGENIC SUBSTRATES 69
6.3.3.1 Chromogenic substrates segment to register the highest growth during the forecast period 69
TABLE 29 IMMUNOHISTOCHEMISTRY MARKET FOR CHROMOGENIC SUBSTRATES,
BY REGION, 2018–2025 (USD MILLION) 70
6.3.4 FIXATION REAGENTS 70
6.3.4.1 North America is the largest market for fixation reagents 70
TABLE 30 IMMUNOHISTOCHEMISTRY MARKET FOR FIXATION REAGENTS, BY REGION, 2018–2025 (USD MILLION) 70
6.3.5 ORGANIC SOLVENTS 71
6.3.5.1 Organic solvents prevent physical damage in specimens and improve clarity while visualizing tissue samples 71
TABLE 31 IMMUNOHISTOCHEMISTRY MARKET FOR ORGANIC SOLVENTS, BY REGION, 2018–2025 (USD MILLION) 71
6.3.6 DILUENTS 71
6.3.6.1 Diluents are used in the preparation of antibody solutions 71
TABLE 32 IMMUNOHISTOCHEMISTRY MARKET FOR DILUENTS, BY REGION,
2018–2025 (USD MILLION) 71
6.3.7 PROTEOLYTIC ENZYMES 72
6.3.7.1 Proteolytic enzymes improve the accessibility of target antibodies 72
TABLE 33 IMMUNOHISTOCHEMISTRY MARKET FOR PROTEOLYTIC ENZYMES,
BY REGION, 2018–2025 (USD MILLION) 72
6.3.8 OTHER REAGENTS 72
6.3.8.1 Other reagents include antigen retrieval solutions, stabilizers, controls, and mounting solutions. 72
TABLE 34 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER REAGENTS, BY REGION, 2018–2025 (USD MILLION) 73
6.4 EQUIPMENT 73
TABLE 35 IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY REGION,
2018–2025 (USD MILLION) 73
TABLE 36 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT,
BY COUNTRY, 2018–2025 (USD MILLION) 73
TABLE 37 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2018–2025 (USD MILLION) 74
TABLE 38 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2018–2025 (USD MILLION) 74
TABLE 39 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY REGION, 2018–2025 (USD MILLION) 74
TABLE 40 IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE,
2018–2025 (USD MILLION) 75
6.4.1 SLIDE-STAINING SYSTEMS 75
6.4.1.1 Development of high-throughput staining systems to
drive market growth 75
TABLE 41 IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS,
BY REGION, 2018–2025 (USD MILLION) 75
TABLE 42 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY COUNTRY, 2018–2025 (USD MILLION) 76
TABLE 43 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY COUNTRY, 2018–2025 (USD MILLION) 76
TABLE 44 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY COUNTRY, 2018–2025 (USD MILLION) 76
TABLE 45 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY REGION, 2018–2025 (USD MILLION) 77
6.4.2 TISSUE PROCESSING SYSTEMS 77
6.4.2.1 Technological advancements and need for automation due to shortage of staff to drive market growth 77
TABLE 46 IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS,
BY REGION, 2018–2025 (USD MILLION) 77
TABLE 47 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 48 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 49 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 50 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY REGION, 2018–2025 (USD MILLION) 79
6.4.3 SLIDE SCANNERS 79
6.4.3.1 Development of advanced multiplexed IHC scanners
to drive market growth 79
TABLE 51 IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY REGION, 2018–2025 (USD MILLION) 79
TABLE 52 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY COUNTRY, 2018–2025 (USD MILLION) 80
TABLE 53 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS,
BY COUNTRY, 2018–2025 (USD MILLION) 80
TABLE 54 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS,
BY COUNTRY, 2018–2025 (USD MILLION) 80
TABLE 55 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS,
BY REGION, 2018–2025 (USD MILLION) 81
6.4.4 OTHER EQUIPMENT 81
TABLE 56 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY REGION, 2018–2025 (USD MILLION) 81
TABLE 57 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2018–2025 (USD MILLION) 81
TABLE 58 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT,
BY COUNTRY, 2018–2025 (USD MILLION) 82
TABLE 59 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT,
BY COUNTRY, 2018–2025 (USD MILLION) 82
TABLE 60 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT,
BY REGION, 2018–2025 (USD MILLION) 82
6.5 KITS 83
TABLE 61 IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY REGION,
2018–2025 (USD MILLION) 83
TABLE 62 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR KITS,
BY COUNTRY, 2018–2025 (USD MILLION) 83
TABLE 63 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY,
2018–2025 (USD MILLION) 84
TABLE 64 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY,
2018–2025 (USD MILLION) 84
TABLE 65 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY REGION,
2018–2025 (USD MILLION) 84
TABLE 66 IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY TYPE,
2018–2025 (USD MILLION) 85
6.5.1 HUMAN IMMUNOHISTOCHEMISTRY KITS 85
6.5.1.1 Increasing focus on cancer research to fuel market growth 85
6.5.2 ANIMAL IMMUNOHISTOCHEMISTRY KITS 85
6.5.2.1 Increasing preclinical drug testing to drive market growth 85

7 IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 67 IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 87
7.2 DIAGNOSTIC APPLICATIONS 87
TABLE 68 IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 87
TABLE 69 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 88
TABLE 70 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 88
TABLE 71 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 88
TABLE 72 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 89
TABLE 73 IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS,
BY DISEASE, 2020–2025 (USD MILLION) 89
7.2.1 CANCER 89
7.2.1.1 Growing use of IHC tests for cancer diagnostics to fuel the
market growth 89
TABLE 74 IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY REGION,
2018–2025 (USD MILLION) 91
TABLE 75 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER,
BY COUNTRY, 2018–2025 (USD MILLION) 91
TABLE 76 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY COUNTRY, 2018–2025 (USD MILLION) 91
TABLE 77 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY COUNTRY, 2018–2025 (USD MILLION) 92
TABLE 78 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY REGION,
2018–2025 (USD MILLION) 92
7.2.2 INFECTIOUS DISEASES 92
7.2.2.1 Growing prevalence of infectious diseases and rising awareness
of early diagnosis to propel market growth 92
TABLE 79 IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY REGION, 2018–2025 (USD MILLION) 93
TABLE 80 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018–2025 (USD MILLION) 93
TABLE 81 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018–2025 (USD MILLION) 93
TABLE 82 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2018–2025 (USD MILLION) 94
TABLE 83 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES,
BY REGION, 2018–2025 (USD MILLION) 94
7.2.3 NEPHROLOGICAL DISEASES 94
7.2.3.1 Wide application of IHC in transplant rejection is expected to
support market growth 94
TABLE 84 IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES,
BY REGION, 2018–2025 (USD MILLION) 95
TABLE 85 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2018–2025 (USD MILLION) 95
TABLE 86 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2018–2025 (USD MILLION) 95
TABLE 87 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2018–2025 (USD MILLION) 96
TABLE 88 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2018–2025 (USD MILLION) 96
7.2.4 AUTOIMMUNE DISEASES 96
7.2.4.1 Availability of numerous primary antibodies and rapid processing
of results make IHC a favorable diagnostic approach 96
TABLE 89 IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES,
BY REGION, 2018–2025 (USD MILLION) 97
TABLE 90 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2018–2025 (USD MILLION) 97
TABLE 91 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2018–2025 (USD MILLION) 97
TABLE 92 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES,
BY COUNTRY, 2018–2025 (USD MILLION) 98
TABLE 93 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES,
BY REGION, 2018–2025 (USD MILLION) 98
7.2.5 NEUROLOGICAL DISEASES 98
7.2.5.1 Increasing global burden of neurological diseases to
propel market growth 98
TABLE 94 IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES,
BY REGION, 2018–2025 (USD MILLION) 99
TABLE 95 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2018–2025 (USD MILLION) 99
TABLE 96 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2018–2025 (USD MILLION) 99
TABLE 97 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2018–2025 (USD MILLION) 100
TABLE 98 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY REGION, 2018–2025 (USD MILLION) 100
7.2.6 OTHER DISEASES 100
TABLE 99 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY REGION, 2018–2025 (USD MILLION) 100
TABLE 100 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY COUNTRY, 2018–2025 (USD MILLION) 101
TABLE 101 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES,
BY COUNTRY, 2018–2025 (USD MILLION) 101
TABLE 102 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES,
BY COUNTRY, 2018–2025 (USD MILLION) 101
TABLE 103 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES,
BY REGION, 2018–2025 (USD MILLION) 102
7.3 RESEARCH APPLICATIONS 102
TABLE 104 IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 102
TABLE 105 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 102
TABLE 106 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 103
TABLE 107 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 103
TABLE 108 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 103
7.3.1 DRUG DEVELOPMENT & TESTING 104
7.3.1.1 Quantitative image analysis makes IHC techniques ideal
for drug testing 104
7.3.2 OTHER RESEARCH APPLICATIONS 104
TABLE 109 IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION) 104
7.4 FORENSIC APPLICATIONS 105
TABLE 110 IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 105
TABLE 111 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 105
TABLE 112 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 106
TABLE 113 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 106
TABLE 114 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 106
 
8 IMMUNOHISTOCHEMISTRY MARKET, BY END USER 107
8.1 INTRODUCTION 108
TABLE 115 IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 108
8.2 HOSPITALS & DIAGNOSTIC LABORATORIES 108
8.2.1 INCREASING INCIDENCE OF CANCER AND INFECTIOUS DISEASES TO INCREASE TESTING VOLUME IN CLINICAL LABORATORIES 108
TABLE 116 IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018–2025 (USD MILLION) 109
TABLE 117 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS
& DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018–2025 (USD MILLION) 109
TABLE 118 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018–2025 (USD MILLION) 109
TABLE 119 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018–2025 (USD MILLION) 110
TABLE 120 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018–2025 (USD MILLION) 110
8.3 ACADEMIC & RESEARCH INSTITUTES 110
8.3.1 INCREASING USE OF IHC TESTS FOR DRUG DEVELOPMENT AND DISEASE DIAGNOSIS TO SUPPORT MARKET GROWTH 110
TABLE 121 IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION) 111
TABLE 122 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC
& RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 111
TABLE 123 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 111
TABLE 124 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 112
TABLE 125 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION) 112
8.4 OTHER END USERS 112
TABLE 126 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION) 113
TABLE 127 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER
END USERS, BY COUNTRY, 2018–2025 (USD MILLION) 113
TABLE 128 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS,
BY COUNTRY, 2018–2025 (USD MILLION) 113
TABLE 129 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS,
BY COUNTRY, 2018–2025 (USD MILLION) 114
TABLE 130 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS,
BY REGION, 2018–2025 (USD MILLION) 114

9 IMMUNOHISTOCHEMISTRY MARKET, BY REGION 115
9.1 INTRODUCTION 116
TABLE 131 IMMUNOHISTOCHEMISTRY MARKET, BY REGION,
2018–2025 (USD MILLION) 116

9.2 NORTH AMERICA 117
FIGURE 16 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET SNAPSHOT 117
TABLE 132 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 118
TABLE 133 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 118
TABLE 134 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES,
BY TYPE, 2018–2025 (USD MILLION) 118
TABLE 135 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS,
BY TYPE, 2018–2025 (USD MILLION) 119
TABLE 136 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT,
BY TYPE, 2018–2025 (USD MILLION) 119
TABLE 137 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 119
TABLE 138 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 120
TABLE 139 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 120
9.2.1 US 120
9.2.1.1 US is the largest country-level market for immunohistochemistry 120
TABLE 140 US: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 121
TABLE 141 US: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE,
2018–2025 (USD MILLION) 121
TABLE 142 US: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE,
2018–2025 (USD MILLION) 122
TABLE 143 US: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 122
TABLE 144 US: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS,
BY DISEASE, 2018–2025 (USD MILLION) 122
TABLE 145 US: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 123
9.2.2 CANADA 123
9.2.2.1 Increasing cancer cases in Canada to support market growth 123
TABLE 146 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 123
TABLE 147 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018–2025 (USD MILLION) 124
TABLE 148 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018–2025 (USD MILLION) 124
TABLE 149 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 124
TABLE 150 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 125
TABLE 151 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 125
 
9.3 EUROPE 125
TABLE 152 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 126
TABLE 153 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 126
TABLE 154 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018–2025 (USD MILLION) 126
TABLE 155 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 156 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 157 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 127
TABLE 158 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 128
TABLE 159 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 128
9.3.1 GERMANY 128
9.3.1.1 Germany to dominate the European IHC market 128
TABLE 160 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 129
TABLE 161 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018–2025 (USD MILLION) 129
TABLE 162 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018–2025 (USD MILLION) 129
TABLE 163 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 130
TABLE 164 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 130
TABLE 165 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 130
9.3.2 FRANCE 131
9.3.2.1 Increasing use of IHC in cancer diagnosis and research to drive market growth 131
TABLE 166 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 131
TABLE 167 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 168 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018–2025 (USD MILLION) 132
TABLE 169 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 132
TABLE 170 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 132
TABLE 171 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 133
9.3.3 UK 133
9.3.3.1 Increasing number of cancer research studies to support
market growth 133
TABLE 172 UK: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 133
TABLE 173 UK: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 174 UK: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 175 UK: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 134
TABLE 176 UK: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS,
BY DISEASE, 2018–2025 (USD MILLION) 135
TABLE 177 UK: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 135
9.3.4 ITALY 135
9.3.4.1 High incidence of cancer to support market growth in Italy 135
TABLE 178 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 136
TABLE 179 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE,
2018–2025 (USD MILLION) 136
TABLE 180 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE,
2018–2025 (USD MILLION) 136
TABLE 181 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 137
TABLE 182 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 137
TABLE 183 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 137
9.3.5 SPAIN 138
9.3.5.1 Increasing demand for personalized medicine will drive the demand for IHC tests to find potential biomarkers 138
TABLE 184 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 138
TABLE 185 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018–2025 (USD MILLION) 138
TABLE 186 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018–2025 (USD MILLION) 139
TABLE 187 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 139
TABLE 188 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 139
TABLE 189 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 140
9.3.6 REST OF EUROPE 140
TABLE 190 ROE: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 140
TABLE 191 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE,
2018–2025 (USD MILLION) 140
TABLE 192 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE,
2018–2025 (USD MILLION) 141
TABLE 193 ROE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 141
TABLE 194 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 141
TABLE 195 ROE: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 142
9.4 ASIA PACIFIC 142
TABLE 196 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 142
FIGURE 17 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET SNAPSHOT 143
TABLE 197 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 143
TABLE 198 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES,
BY TYPE, 2018–2025 (USD MILLION) 144
TABLE 199 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS,
BY TYPE, 2018–2025 (USD MILLION) 144
TABLE 200 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT,
BY TYPE, 2018–2025 (USD MILLION) 144
TABLE 201 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 145
TABLE 202 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 145
TABLE 203 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 145
9.4.1 JAPAN 146
9.4.1.1 Japan to dominate the Asia Pacific immunohistochemistry market 146
TABLE 204 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 146
TABLE 205 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018–2025 (USD MILLION) 146
TABLE 206 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018–2025 (USD MILLION) 147
TABLE 207 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 147
TABLE 208 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 147
TABLE 209 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 148
9.4.2 CHINA 148
9.4.2.1 China to register the highest growth during the forecast period 148
TABLE 210 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 148
TABLE 211 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018–2025 (USD MILLION) 149
TABLE 212 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018–2025 (USD MILLION) 149
TABLE 213 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 149
TABLE 214 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 150
TABLE 215 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 150
9.4.3 INDIA 150
9.4.3.1 India is a key destination for high-end pathology and diagnostic services 150
TABLE 216 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 151
TABLE 217 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018–2025 (USD MILLION) 151
TABLE 218 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018–2025 (USD MILLION) 151
TABLE 219 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 152
TABLE 220 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 152
TABLE 221 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 152
9.4.4 REST OF ASIA PACIFIC 153
TABLE 222 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 153
TABLE 223 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018–2025 (USD MILLION) 153
TABLE 224 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018–2025 (USD MILLION) 154
TABLE 225 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 154
TABLE 226 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 154
TABLE 227 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 155
9.5 REST OF THE WORLD 155
TABLE 228 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY REGION,
2018–2025 (USD MILLION) 155
TABLE 229 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 155
TABLE 230 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE,
2018–2025 (USD MILLION) 156
TABLE 231 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE,
2018–2025 (USD MILLION) 156
TABLE 232 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE,
2018–2025 (USD MILLION) 156
TABLE 233 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 157
TABLE 234 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 157
TABLE 235 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 157
9.5.1 LATIN AMERICA 158
9.5.1.1 Increasing incidence of cancer in Latin America is driving
market growth 158
TABLE 236 LATAM: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 158
TABLE 237 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018–2025 (USD MILLION) 158
TABLE 238 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018–2025 (USD MILLION) 158
TABLE 239 LATAM: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 159
TABLE 240 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 159
TABLE 241 LATAM: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 159
9.5.2 MIDDLE EAST AND AFRICA 160
9.5.2.1 Government initiatives focused on boosting healthcare infrastructure development to drive market growth 160
TABLE 242 MEA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 160
TABLE 243 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE,
2018–2025 (USD MILLION) 160
TABLE 244 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE,
2018–2025 (USD MILLION) 161
TABLE 245 MEA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 161
TABLE 246 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018–2025 (USD MILLION) 161
TABLE 247 MEA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER,
2018–2025 (USD MILLION) 162

10 COMPETITIVE LANDSCAPE 163
10.1 INTRODUCTION 163
10.2 MARKET RANKING ANALYSIS 163
FIGURE 18 COMPANY RANKING IN THE IMMUNOHISTOCHEMISTRY MARKET, 2019 163
10.3 MARKET EVALUATION FRAMEWORK 164
TABLE 248 MARKET EVALUATION FRAMEWORK: PRODUCT DEVELOPMENT & LAUNCH—THE MAJOR STRATEGY ADOPTED BY PLAYERS 164
10.4 COMPETITIVE SCENARIO 164
10.4.1 KEY PRODUCT LAUNCHES 164
10.4.2 KEY COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS 165
10.4.3 KEY EXPANSIONS 166
10.4.4 KEY ACQUISITIONS 166

11 COMPANY EVALUATION MATRIX AND COMPANY PROFILES 167
11.1 OVERVIEW 167
11.2 GLOBAL IMMUNOHISTOCHEMISTRY MARKET: COMPANY EVALUATION MATRIX 167
11.2.1 STARS 167
11.2.2 EMERGING LEADERS 167
11.2.3 PERVASIVE 167
11.2.4 EMERGING COMPANIES 168
FIGURE 19 GLOBAL IMMUNOHISTOCHEMISTRY MARKET: COMPANY
EVALUATION MATRIX, 2019 168
11.3 COMPANY PROFILES 169
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.3.1 F. HOFFMANN-LA ROCHE AG 169
FIGURE 20 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2019) 169
11.3.2 DANAHER CORPORATION 174
FIGURE 21 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 174
11.3.3 AGILENT TECHNOLOGIES, INC. 178
FIGURE 22 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019) 178
11.3.4 MERCK KGAA 182
FIGURE 23 MERCK KGAA: COMPANY SNAPSHOT (2019) 182
11.3.5 BIO-RAD LABORATORIES, INC. 187
FIGURE 24 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019) 187
11.3.6 PHC HOLDINGS CORPORATION 189
11.3.7 BIO-TECHNE CORPORATION 192
FIGURE 25 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2019) 192
11.3.8 ABCAM PLC 194
FIGURE 26 ABCAM COMPANY: COMPANY SNAPSHOT (2019) 194
11.3.9 BECTON, DICKINSON AND COMPANY 197
FIGURE 27 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 197
11.3.10 PERKINELMER 201
FIGURE 28 PERKINELMER: COMPANY SNAPSHOT (2019) 201
11.3.11 CELL SIGNALING TECHNOLOGY, INC. 204
11.3.12 BIO SB, INC. 208
11.3.13 MILTENYI BIOTEC 212
11.3.14 CANDOR BIOSCIENCE GMBH 215
11.3.15 SAKURA FINETEK JAPAN CO., LTD. 216
11.3.16 EAGLEBIO 219
11.3.17 BIOCARE MEDICAL, LLC 220
11.3.18 ELABSCIENCE, INC. 223
11.3.19 BIOGENEX 224
11.3.20 DIAGNOSTIC BIOSYSTEMS 226
*Details on Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
 
12 APPENDIX 230
12.1 DISCUSSION GUIDE 230
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 233
12.3 AVAILABLE CUSTOMIZATIONS 235
12.4 RELATED REPORTS 235
12.5 AUTHOR DETAILS 236


★調査レポート[免疫組織化学（IHC）の世界市場予測：製品別（抗体、試薬（発色性基質）、キット）、用途別（診断（癌、感染症）、研究、法医学）、エンドユーザー別（病院、診断研究所、学術）] ( Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer, Infectious), Research, Forensic), End User (Hospitals, Diagnostic Laboratories, Academic) - Global Forecast to 2025 / BT 4780) 販売に関する免責事項
[免疫組織化学（IHC）の世界市場予測：製品別（抗体、試薬（発色性基質）、キット）、用途別（診断（癌、感染症）、研究、法医学）、エンドユーザー別（病院、診断研究所、学術）] ( Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer, Infectious), Research, Forensic), End User (Hospitals, Diagnostic Laboratories, Academic) - Global Forecast to 2025 / BT 4780) についてEメールでお問い合わせ
◆関連調査資料◆
  • 世界の溶媒蒸発市場：蒸発器種類別（ロータリー蒸発器、窒素ブローダウン蒸発器、遠心蒸発器）、エンドユーザー別（医薬＆バイオ医薬品、診断研究所、研究所＆学術研究所）、地域別
    AST 7447 / MarketsandMarkets / 2019年11月22日 / MarketsandMarkets社は、溶媒蒸発の世界市場規模が2019年487百万ドルから2024年694百万ドルまで年平均7.3%成長すると予測しています。本書は、世界の溶媒蒸発市場について調査・分析し、市場概要、種類別（ロータリー蒸発器、窒素ブローダウン蒸発器、遠心蒸発器）分析、エンドユーザー別（医薬＆バイオ医薬品、診断研究所、研究所＆学術研究所）分析、地域別分析、競合環境、企業概要などを掲載しております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界の溶媒蒸発市場：種類別（ロータリー蒸発器、窒素ブローダウン蒸発器、遠心蒸発器） ・世界の溶媒蒸発市場：エンドユーザー別（医薬＆バイオ医薬品、診断研究所、研究所＆学術研究所） ・世界の溶媒蒸発市場：地域別 ・競合環境...“The global solvent evaporators market size is projected to grow at a CAGR of 7.3%.” The global solvent evaporators market size is expected to reach USD 694 million by 2024 from an estimated USD 487 million in 2019, at a CAGR of 7.3%. The growth of the biologics sector, increasing research & development expenditure, rising purity demands in end-use markets, and the growing development of large molecule biopharmaceuticals are the primary growth factors for this market. The untapped markets in emerging regions and the increasing demand for laboratory automation are expected to offer significant growth opportunities for players in the...
  • 世界の溶媒蒸発市場：蒸発器種類別（ロータリー蒸発器、窒素ブローダウン蒸発器、遠心蒸発器）、エンドユーザー別（医薬＆バイオ医薬品、診断研究所、研究所＆学術研究所）、地域別
    AST 7447 / MarketsandMarkets / 2019年11月22日 / MarketsandMarkets社は、溶媒蒸発の世界市場規模が2019年487百万ドルから2024年694百万ドルまで年平均7.3%成長すると予測しています。本書は、世界の溶媒蒸発市場について調査・分析し、市場概要、種類別（ロータリー蒸発器、窒素ブローダウン蒸発器、遠心蒸発器）分析、エンドユーザー別（医薬＆バイオ医薬品、診断研究所、研究所＆学術研究所）分析、地域別分析、競合環境、企業概要などを掲載しております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界の溶媒蒸発市場：種類別（ロータリー蒸発器、窒素ブローダウン蒸発器、遠心蒸発器） ・世界の溶媒蒸発市場：エンドユーザー別（医薬＆バイオ医薬品、診断研究所、研究所＆学術研究所） ・世界の溶媒蒸発市場：地域別 ・競合環境...“The global solvent evaporators market size is projected to grow at a CAGR of 7.3%.” The global solvent evaporators market size is expected to reach USD 694 million by 2024 from an estimated USD 487 million in 2019, at a CAGR of 7.3%. The growth of the biologics sector, increasing research & development expenditure, rising purity demands in end-use markets, and the growing development of large molecule biopharmaceuticals are the primary growth factors for this market. The untapped markets in emerging regions and the increasing demand for laboratory automation are expected to offer significant growth opportunities for players in the...
  • 新型コロナウイルス感染症の影響による対人関係能力育成（SEL）の世界市場予測：コンポーネント別（ソリューション、サービス）、種類別（ウェブ、アプリケーション）、エンドユーザー別（幼稚園、小学校、中学校・高校）、地域別
    TC 7519 / MarketsandMarkets / 2020年7月15日 / MarketsandMarkets社は新型コロナウイルス感染症の影響による対人関係能力育成（SEL）の世界市場が2020年15億ドルから2025年39億ドルまで、年平均18.6％成長すると予想しています。本調査レポートでは、新型コロナウイルス感染症の影響による対人関係能力育成（SEL）の世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、エコシステム・拡張エコシステムへの影響、コンポーネント別（ソリューション、サービス）分析、種類別（ウェブ、アプリ）分析、エンドユーザー別（幼稚園、小学校、中・高等学校）分析、地域別分析、主要ベンダーなどを含め、ご提供しております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・エコシステム・拡張エコシステムへの影響 ・新型コロナウイルス感染症の影響による対人関係能力育成（SEL）の世界市場規模：コンポーネント別（ソリューション、サービス） ・新型コロナウイルス感染症の影響による対人関係能力育成（SEL）の世界市場規模：種類別（ウェブ、アプリ） ・新型コロナウイルス感染症の影響による対人関係能力育成（SEL）の世界市場規模：エンドユーザー別（幼稚園、小学校、中・高等学校） ・新型コロナウイルス感染症の影響による対人関係能力育成（SEL）の世界市場規模：地域別 ・主要ベンダー...“Higher adoption of SEL tools inQ4 of 2020 and Q1 of 2021” In an optimistic scenario, MarketsandMarkets expects the COVID-19 impact on the global social and emotional learning (SEL) market size is expected to grow from USD 1.5 billion in 2020 to USD 3.9 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 18.6% during the forecast period. Major factors driving the growth of the COVID-19 impact on the global social and emotional learning (SEL) market includes higher adoption of social and emotional learning tools in Q4 of 2020 and Q1 of 2021, and the promotion of SEL...
  • 陰圧閉鎖療法（NPWT）の世界市場予測：種類別（従来型、使い捨てNPWT、付属品、レンタル・販売）、創傷種類別（外科、外傷、糖尿病性足病変、閉鎖、静脈性潰瘍）、エンドユーザー別（病院、在宅医療）
    MD 6656 / MarketsandMarkets / 2020年4月30日 / MarketsandMarkets社は陰圧閉鎖療法（NPWT）の世界市場が、2020年24億ドルから2025年32憶ドルまで、年平均6.1％成長すると予測しています。本調査レポートでは、陰圧閉鎖療法（NPWT）の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、種類別（従来型NPWT、使い捨てNPWT、付属品）分析、創傷種類別（外科、外傷、糖尿病性足病変、閉鎖、静脈性潰瘍）分析、エンドユーザー別（病院、在宅医療、その他）分析、地域別分析、競争状況、企業概要などを含め、今後の方向性を提示しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場動向 ・陰圧閉鎖療法（NPWT）の世界市場：種類別（従来型NPWT、使い捨てNPWT、付属品） ・陰圧閉鎖療法（NPWT）の世界市場：創傷種類別（外科、外傷、糖尿病性足病変、閉鎖、静脈性潰瘍） ・陰圧閉鎖療法（NPWT）の世界市場：エンドユーザー別（病院、在宅医療、その他） ・陰圧閉鎖療法（NPWT）の世界市場：地域別...“The global NPWT devices market is projected to grow at a CAGR of 6.1%.” The global NPWT devices market is projected to reach USD 3.2 billion by 2025 from USD 2.4 billion in 2020, at a CAGR of 6.1%. Factors such as the rising prevalence of diabetes, government initiatives to prevent SSIs, increasing spending on chronic and surgical wounds, and the high rate of cesarean sections in elderly mothers are driving the growth of the NPWT devices market. On the other hand, the high cost of the NPWT devices, low adoption rates, and the complications associated with the use of...
  • リッチコミュニケーションサービス（RCS）の世界市場予測：用途別（広告キャンペーン、コンテンツ配信、統合ソリューション）、エンドユーザー別（消費者、企業）、企業規模別、産業別、地域別
    TC 2679 / MarketsandMarkets / 2020年7月23日 / MarketsandMarkets社はリッチコミュニケーションサービス（RCS）の世界市場が2020年52億ドルから2025年117億ドルまで、年平均17.6％成長すると予想しています。本調査レポートでは、リッチコミュニケーションサービス（RCS）の世界市場について、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、用途別（広告キャンペーン、コンテンツ配信、統合ソリューション、その他）分析、エンドユーザー別（消費者、企業）分析、企業規模別（中小企業、大企業）分析、産業別（金融、通信・IT、媒体・娯楽、観光・物流、小売・Eコマース）分析、地域別分析、競争状況、企業情報などを総合的、多面的に調査・分析しました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・リッチコミュニケーションサービス（RCS）の世界市場規模：用途別（広告キャンペーン、コンテンツ配信、統合ソリューション、その他） ・リッチコミュニケーションサービス（RCS）の世界市場規模：エンドユーザー別（消費者、企業） ・リッチコミュニケーションサービス（RCS）の世界市場規模：企業規模別（中小企業、大企業） ・リッチコミュニケーションサービス（RCS）の世界市場規模：産業別（金融、通信・IT、媒体・娯楽、観光・物流、小売・Eコマース）...“Increasing number of advertising and marketing companies to drivethe Rich Communication Services(RCS) market growth.” The global RCS market size is projected to grow from USD 5.2 billion in 2020 to USD 11.7 billion by 2025, at a CAGR of 17.6% during 2020–2025. Major growth factors for the market include Increasing investments on digital marketing across the enterprise verticals. “The COVID-19 outbreak has significantly impacted several communication service providers across the globe.” Major countries from North America, Europe, APAC, MEA, and Latin America are badly affected in the pandemic and industry giants from several regions are taking initiatives to enable consumers...
  • ヘルスケア・ライフサイエンスにおける自然言語処理（NLP）の世界市場予測：構成要素別、NLP種類別、用途別（パターン・画像認識、自動コーディング）、展開モード別、組織規模別、エンドユーザー別、地域別
    TC 3660 / MarketsandMarkets / 2020年4月30日 / MarketsandMarkets社はヘルスケア・ライフサイエンスにおける自然言語処理（NLP）の世界市場が、2020年15億ドルから2025年37憶ドルまで、年平均20.5％成長すると予測しています。本調査レポートでは、ヘルスケア・ライフサイエンスにおける自然言語処理（NLP）の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向・産業トレンド、構成要素別（スタンドアロンソリューション、サービス）分析、NLP種類別（ルールベース自然言語処理、統計的自然言語処理、ハイブリッド自然言語処理）分析、展開モード別（オンプレミス、クラウド）分析、組織規模別（大企業、中小企業）分析、用途別（パターン・画像認識、自動コーディング、テキスト・音声分析）分析、エンドユーザー別（医師、研究者、患者、臨床医）分析、地域別分析、競争状況、企業概要などを含め、今後の方向性を提示しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場動向・産業トレンド ・ヘルスケア・ライフサイエンスにおける自然言語処理（NLP）の世界市場：構成要素別（スタンドアロンソリューション、サービス） ・ヘルスケア・ライフサイエンスにおける自然言語処理（NLP）の世界市場：NLP種類別（ルールベース自然言語処理、統計的自然言語処理、ハイブリッド自然言語処理） ・ヘルスケア・ライフサイエンスにおける自然言語処理（NLP）の世界市場：展開モード別（オンプレミス、クラウド） ・ヘルスケア・ライフサイエンスにおける自然言語処理（NLP）の世界市場：組織規模別（大企業、中小企業）..."The global Natural Language Processing (NLP) in healthcare and life sciences market size to grow at a CAGR of 20.5% during the forecast period" The Natural Language Processing (NLP) in healthcare and life sciences market size is projected to grow from USD 1.5 billion in 2020 to USD 3.7 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 20.5% during the forecast period. The major growth factors of the NLP in healthcare and life sciences market include the growing demand for improving Electronic Health Records (EHRs) data usability to better patient care, and ability to analyze and extract...
  • 解剖病理学の世界市場予測：製品・サービス別（器具（組織処理装置、ミクロトーム）、消耗品（抗体）、組織病理学）、用途別（疾患診断（癌（胃腸、肺））、エンドユーザー別、地域別
    MD 5104 / MarketsandMarkets / 2020年8月28日 / MarketsandMarkets社は解剖病理学の世界市場が2020年333億ドルから2025年468億ドルまで、年平均7.1％成長すると予測しております。本調査レポートでは、解剖病理学の世界市場について詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別（サービス、消耗品、器具）分析、用途別（病気診断、医学研究）分析、エンドユーザー別（病院研究所、臨床検査室、その他）分析、地域別分析、競争状況、企業情報、隣接市場などを含めております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・解剖病理学の世界市場規模：製品・サービス別（サービス、消耗品、器具） ・解剖病理学の世界市場規模：用途別（病気診断、医学研究） ・解剖病理学の世界市場規模：エンドユーザー別（病院研究所、臨床検査室、その他） ・解剖病理学の世界市場規模：地域別...“Anatomic pathology market to register a CAGR of 7.1% from 2020 to 2025.” The global anatomic pathology market size is projected to reach a value of USD 46.8 billion by 2025 from USD 33.3 billion in 2020, at a CAGR of 7.1% during the forecast period. The growth in this market is attributed to the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the...
  • ハイパーコンバージドインフラストラクチャー（HCI）の世界市場予測：コンポーネント別（ハードウェア、ソフトウェア）、用途別（ROBO、VDI、データセンター統合、バックアップ/リカバリ/災害復旧）、エンドユーザー別、組織規模別、企業別、地域別
    TC 6845 / MarketsandMarkets / 2020年7月16日 / MarketsandMarkets社はハイパーコンバージドインフラストラクチャー（HCI）の世界市場が2020年78億ドルから2025年271億ドルまで、年平均28.1％成長すると予想しています。本調査レポートでは、ハイパーコンバージドインフラストラクチャー（HCI）の世界市場について、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、コンポーネント別（ハードウェア、ソフトウェア）分析、用途別（データセンター統合、仮想化クリティカルアプリケーション、仮想デスクトップインフラストラクチャ（VDI）、リモートオフィス/ブランチオフィス）分析、組織規模別（中小企業、大企業）分析、エンドユーザー別（企業、コロケーションプロバイダー、クラウドプロバイダー）分析、エンドユーザー別（企業、コロケーションプロバイダー、クラウドプロバイダー）分析、企業別（金融、IT・通信、医療、政府機関、エネルギー）分析、地域別分析、競争状況、企業情報などを総合的、多面的に調査・分析しました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・ハイパーコンバージドインフラストラクチャー（HCI）の世界市場規模：コンポーネント別（ハードウェア、ソフトウェア） ・ハイパーコンバージドインフラストラクチャー（HCI）の世界市場規模：用途別（データセンター統合、仮想化クリティカルアプリケーション、仮想デスクトップインフラストラクチャ（VDI）、リモートオフィス/ブランチオフィス） ・ハイパーコンバージドインフラストラクチャー（HCI）の世界市場規模：組織規模別（中小企業、大企業） ・ハイパーコンバージドインフラストラクチャー（HCI）の世界市場規模：エンドユーザー別（企業、コロケーションプロバイダー、クラウドプロバイダー）...“Increasing data protection and disaster recovery requirements to drive the global HCI market.” The global HCI market size is expected to grow from USD 7.8 billion in 2020 to USD 27.1 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 28.1% during the forecast period. The major growth drivers for the market are the Increasing data protection and disaster recovery requirements to rise demand for HCI and rising adoption of HCI among organizations to reduce Capital Expendeture (CAPEX) and Operational Expendeture (OPEX). However, restriction on hypervisor selection restrains the market growth. “The software segment is estimated to constitute...
  • 新型コロナウイルス感染症の影響によるIVD（体外診断）の世界市場予測：技術別（PCR、NGS、ELISA、迅速検査、血液学、止血、臨床化学、微生物学検査、尿検査）、エンドユーザー別、地域別
    MD 7631 / MarketsandMarkets / 2020年5月20日 / MarketsandMarkets社は新型コロナウイルス感染症の影響によるIVD（体外診断）の世界市場が2022年610億ドルから2025年まで、年平均6.5％成長すると予測しています。本調査レポートでは、新型コロナウイルス感染症の影響によるIVD（体外診断）の世界市場を詳細に調査・分析し、IVD診断産業システム、産業インサイト、新型コロナウイルス感染症影響によるIVD診断市場評価、エンドユーザー別（病院ベース検査室、独立型実験室、実験室参考文献、ケアポイント＆セルフテスト、研究者＆アカデミア、その他）、国家別 、競争状況、主要産業使用事例などを含め、ご提供いたします。 ・IVD診断産業システム ・産業インサイト ・新型コロナウイルス感染症の影響によるIVD診断市場評価 ・IVD診断の世界市場：エンドユーザー別（病院ベース検査室、独立型実験室、実験室参考文献、ケアポイント＆セルフテスト、研究者＆アカデミア、その他） ・新型コロナウイルス感染症の影響によるIVD診断市場 ：国家別 ・競争状況 ・主要産業使用事例..."The global in-vitro diagnostics market is expected to be valued at USD 61.0 billion in 2020, growing at a CAGR of 6.5% during 2020-2025." The global in-vitro diagnostics market size is expected to be valued at USD 61.0 billion in 2020, growing at a CAGR of 6.5% during 2020-2025. The demand for in-vitro diagnostic products due to the COVID-19 pandemic is expected to increase mainly due to factors such as a sharp rise in market demand for PCR, NGS, serology based rapid-test products, the supportive regulatory landscape for product development & commercialization, and a sharp rise in target patient population....
  • ソフトウェア定義型広域ネットワーク(SD-WAN)の世界市場予測：コンポーネント別（ソリューション（ソフトウェア・アプライアンス）、サービス）、展開タイプ別（オンプレミス、クラウド）、エンドユーザー別（サービスプロバイダー、産業）、地域別
    TC 3991 / MarketsandMarkets / 2020年8月28日 / MarketsandMarkets社はソフトウェア定義型広域ネットワーク(SD-WAN)の世界市場が2020年19億ドルから2025年84億ドルまで、年平均34.5％成長すると予測しております。本調査レポートでは、ソフトウェア定義型広域ネットワーク(SD-WAN)の世界市場について詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、ネットワーク種類別（マルチプロトコルラベルスイッチング、ブロードバンド、長期的進化、ハイブリッド）分析、コンポーネント別（ソリューション、ソフトウェア、サービス）分析、展開モード別（オンプレミス、クラウド）分析、組織規模別（中小企業、大企業）分析、エンドユーザー別（サービスプロバイダー、産業）分析、地域別分析、競争状況、企業情報などを含めております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・ソフトウェア定義型広域ネットワーク(SD-WAN)の世界市場規模：ネットワーク種類別（マルチプロトコルラベルスイッチング、ブロードバンド、長期的進化、ハイブリッド） ・ソフトウェア定義型広域ネットワーク(SD-WAN)の世界市場規模：コンポーネント別（ソリューション、ソフトウェア、サービス） ・ソフトウェア定義型広域ネットワーク(SD-WAN)の世界市場規模：展開モード別（オンプレミス、クラウド） ・ソフトウェア定義型広域ネットワーク(SD-WAN)の世界市場規模：組織規模別（中小企業、大企業）..."SD-WAN contribution in OPEX reduction and increasing number of cloud-based solutionsto drive the SD-WANmarket" The global SD-WANmarket size is expected to grow from USD 1.9 billion in 2020 to USD 8.4 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 34.5% during the forecast period.The increasing number of cloud-based applications increases traffic in the network and SD-WAN provides better cloud connectivity than MPLS does. As a result, enterprises are expected to opt for SD-WAN. The deployment of SD-WAN also enables network operators to save capital and reduce OPEX. To handle increased traffic, enterprises need to move toward more...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆